IFN production following viral infection results in significant alterations in cellular glucose metabolism, and understanding these changes is essential, as insights into influenza virus replication have elucidated novel therapeutic avenues that rely on targeted inhibition of such cellular metabolic pathways [86]. This evidence concerns the gene IFNA1 and viral infectious disease.